We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$84.7B
AUM Growth
+$3.15B
Cap. Flow
-$3.2B
Cap. Flow %
-3.77%
Top 10 Hldgs %
10.93%
Holding
2,264
New
35
Increased
617
Reduced
853
Closed
525

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$128M
2
DHR icon
Danaher
DHR
+$114M
3
ZBRA icon
Zebra Technologies
ZBRA
+$112M
4
AIZ icon
Assurant
AIZ
+$92.7M
5
EXC icon
Exelon
EXC
+$92.2M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Healthcare 15.17%
3 Financials 13.51%
4 Industrials 10.72%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DEA
1501
Easterly Government Properties
DEA
$1.18B
$327K ﹤0.01%
9,153
+1,322
+17% +$51.4K
LTC
1502
LTC Properties
LTC
$2.16B
$322K ﹤0.01%
9,052
-96
-1% -$3.65K
ELME
1503
Elme Communities
ELME
$132M
$319K ﹤0.01%
17,913
-3,923
-18% -$72.3K
BEN icon
1504
Franklin Resources
BEN
$16.9B
$311K ﹤0.01%
11,778
RIVN icon
1505
Rivian
RIVN
$22.9B
$305K ﹤0.01%
16,531
+6,837
+71% +$201K
SNAP icon
1506
Snap
SNAP
$7.32B
$303K ﹤0.01%
33,840
+7,554
+29% +$74.5K
CROX icon
1507
Crocs
CROX
$6.69B
$295K ﹤0.01%
2,725
+1,312
+93% +$116K
PLTR icon
1508
Palantir
PLTR
$295B
$287K ﹤0.01%
44,742
-2,764
-6% -$21K
SURF
1509
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$287K ﹤0.01%
350,000
QFIN icon
1510
Qfin Holdings
QFIN
$1.61B
$283K ﹤0.01%
13,889
HPP
1511
Hudson Pacific Properties
HPP
$834M
$282K ﹤0.01%
4,145
-1,924
-32% -$143K
XRAY icon
1512
Dentsply Sirona
XRAY
$2.59B
$281K ﹤0.01%
8,847
-198
-2% -$5.97K
DQ
1513
Daqo New Energy
DQ
$790M
$273K ﹤0.01%
7,076
+855
+14% +$41.9K
VRE
1514
DELISTED
Veris Residential
VRE
$271K ﹤0.01%
16,981
-922
-5% -$13.6K
LYFT icon
1515
Lyft
LYFT
$5.39B
$267K ﹤0.01%
24,184
-20,898
-46% -$252K
RCL icon
1516
Royal Caribbean
RCL
$78.7B
$262K ﹤0.01%
5,300
+1,866
+54% +$97.8K
PBYI icon
1517
Puma Biotechnology
PBYI
$406M
$259K ﹤0.01%
61,255
DASH icon
1518
DoorDash
DASH
$75.3B
$259K ﹤0.01%
5,298
+1,350
+34% +$70.1K
LBRDK icon
1519
Liberty Broadband Class C
LBRDK
$4.15B
$257K ﹤0.01%
3,374
CHCT
1520
Community Healthcare Trust
CHCT
$537M
$256K ﹤0.01%
7,164
+1,841
+35% +$62.7K
FSP
1521
Franklin Street Properties
FSP
$44.8M
$256K ﹤0.01%
93,612
PTON icon
1522
Peloton Interactive
PTON
$2.63B
$255K ﹤0.01%
32,103
-2,255
-7% -$21.6K
BZ icon
1523
Kanzhun
BZ
$6.89B
$253K ﹤0.01%
12,421
+2,645
+27% +$43.4K
RTL
1524
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$247K ﹤0.01%
41,641
+14,354
+53% +$91.3K
LU icon
1525
Lufax Holding
LU
$1.2B
$246K ﹤0.01%
31,698
-18,154
-36% -$138K

Similar funds

Macquarie Group's Q4 2022 Portfolio in Review

As of Q4 2022, Macquarie Group held 2,264 positions worth $84.7B, up 3.9% from $81.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group withdrew a net $3.2B in Q4 2022, closing 525 positions and reducing 853 holdings. Its most notable exit was Abiomed Inc, an estimated $124M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in iShares 0-5 Year Investment Grade Corporate Bond ETF worth $58.3M.

  • Macquarie Group's largest Q4 2022 buy was iShares 0-5 Year Investment Grade Corporate Bond ETF: 1,218,670 shares worth $58.3M.
  • Macquarie Group added most to L3Harris in Q4 2022, an estimated $128M increase.
  • Macquarie Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $189M.
  • Macquarie Group fully exited Abiomed Inc in Q4 2022, selling an estimated $124M.
  • Macquarie Group's ten largest holdings make up 11% of its $84.7B portfolio in Q4 2022.
  • Macquarie Group opened 35 new positions and closed 525 in Q4 2022.
  • Macquarie Group's portfolio value rose 3.9% quarter-over-quarter to $84.7B.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.